drugset / Trial / NCT03005678
Denosumab Versus Bisphosphonates (Alendronate) in GIOP
RandomizedParallel-groupOpen-labelTreatment
Summary
A randomized controlled trial to compare for the efficacy and tolerability of denosumab and oral alendronate in the management of glucocorticoid induced osteoporosis
Timeline
- Start
- 2017-04-01
- Primary completion
- 2019-11-01
- Completion
- 2020-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alendronic Acid | Small molecule | 70 mg | Oral |
| Comparator | Denosumab | Monoclonal antibody | 60 mg | Subcutaneous |